Member Info for ChrisToffer

That's a very sweeping Bruce and suggests a binary answer to the question mark around this new strain. As Scinv points out, it'll never be as simple or as black and white as that.

It doesn't really matter that much BF. As i understand it, It's an OTC trade rate, mostly driven by PI's therefore volume is usually fairly low. Any big US player or II will be buying shares on AIM.

https://www.covidtrialathome.com/

Hahaha

Shows a lot of new investors here now that Punit quote gets questioned ha! Good luck everyone, this is a long overdue correction and well done for those who held through!

Load of nonsense 110. All we've seen from the majority of governments this year is mass incompetence due to a complete lack of understanding of this novel virus. Some gave faired OK (NZ and far Eastern countries) but the idea that theyre all conspiring to take advantage of it is a stretch. That theyre somehow succeeding is utter ******

I'm interested to know how a covid sceptic ends up on an investment BB for treatment that can tread covid.

If they were to follow Gileads example with Remdesivir then it may get outlicenced to a generic drug maker in countries like India.

ZK you need to check your math. 200 million shares are in issue. Each billion in value is a fiver a share.

Hi Tyla, The Data Monitoring Committee/Board will have access to the data and can recommend stopping the trial for good/bad efficacy or safety reasons. However now that the trial has been reduced to 600 patients they may just power through it.

Dry your eyes lads. 150p is 300m market cap and its gonna take some serious pressure to get through that. If it does break then who knows where we go next

So ya want him to do more PR but not do any interviews?

That;s right Shpunken, i'm nnot sure the full meaning of fast tracking with the FDA has sunk in yet. Not just that but when the US announce the trial and if it gets included in activ then it'll reach new highs before any interims.

Be surprised if we don't get one in the next few days

VP89, they're over-the-counter (OTC)trades facilitated by that market in the US. It's like me selling you some of my shares without going through AIM. There are still only 200m shares of Synairgen in issue. That doesn't change unless they issue more.

Completely agree Mat/Syn. We should not shy away from big numbers here. SNG don't need to save the world to reach a multi billion valuation, even though a lot of us feel that this drug will play a huge part in fighting off the virus.

Migs, you think 1.2 billion is a stretch if P3 is successful?

Did ya notice the RNS said the trial hadn't started 2 weeks ago when you were telling everyone it had?

Hahahaha brilliant Big!

Have to say i'm a lot more comfortable that its the same (or thereabouts).